Survey: China, Malaysia demonstrate strong pharma growth

05/14/2013 | BioSpectrum Asia · BioSpectrum Asia

Despite slowing fiscal growth in China, government investments are ensuring that the country's pharmaceutical industry will continue to expand and attract private investment. Malaysia, too, is rapidly becoming a center of pharmaceutical and medical device manufacturing, with estimates that the medtech market there will hit $2.8 billion in four years. The assessments of both countries come from the BioSpectrum Asia Top 20 Survey.

View Full Article in:

BioSpectrum Asia · BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD